Exagen makes AVISE brand blood tests that help doctors diagnose autoimmune and related rheumatic diseases. It last closed at $3.76 on Nov 17, down 0.27% on the day. The average 12-month price target from 3 analysts is $9.67 (+157.1% from the last close), with a high of $11.00 and a low of $9.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Each firm's latest rating on XGN in the past 90 days
Average 12-month target
$9.67
▲ 157.1% upside
Based on 3 analysts who set a price target on XGN in the past 90 days. The average target is $9.67, with a high of $11.00 and a low of $9.00, compared with the last close of $3.76.
Low $9.00Avg $9.67High $11.00
Blue marker: last close $3.76
Highest target$11.00
Average target$9.67
Lowest target$9.00
Latest rating changes
Canaccord GenuityTarget lowered
Nov 11Buy$11 → $9
BTIGReiterated
Nov 11Buy$9
Canaccord GenuityMaintained
Oct 19Buy$11
TD CowenMaintained
Oct 13Buy$11
B. Riley SecuritiesReiterated
Aug 5Buy$12
Date
Firm
Action
Rating
Price target
Nov 11
Canaccord Genuity
Target lowered
Buy
$11 → $9
Nov 11
BTIG
Reiterated
Buy
$9
Oct 19
Canaccord Genuity
Maintained
Buy
$11
Oct 13
TD Cowen
Maintained
Buy
$11
Aug 5
B. Riley Securities
Reiterated
Buy
$12
Loading…
Technical Analysis
XGN · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, oversold
The stock is 80% below its 20 day and 101% below its 50 day average. It is 36% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the Pivot S1 at $3.63, and the nearest resistance the Pivot at $3.77.
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 19.4%/day
Key levels
$9.2252 week high+145.2%
$7.5650 day average+101.1%
$6.7820 day average+80.3%
$6.70100 day average+78.2%
$5.12200 day average+36.2%
$4.85Swing high (Jun 15)+29.0%
$3.90Pivot R1+3.7%
$3.77Pivot+0.3%
$3.76Last close
$3.63Pivot S1−3.5%
$2.5952 week low−31.1%
Indicators
RSI (14)
27.26
Oversold below 30
Oversold
MACD
-1.03
Below its signal line
Bearish
Stochastic
2.8
Near the bottom of its range
Oversold
ADX (14)
34.7
Trending down
Williams %R
-97.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-140.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−54.9%
Change over 10 sessions
Bearish
ATR (14)
$0.73
Typical daily range, 19.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 33.0%/day
Key levels
$9.2252 week high+145.2%
$7.5650 day average+101.1%
$6.7820 day average+80.3%
$6.70100 day average+78.2%
$5.12200 day average+36.2%
$4.85Swing high (Jun 15)+29.0%
$3.90Pivot R1+3.7%
$3.77Pivot+0.3%
$3.76Last close
$3.63Pivot S1−3.5%
$2.5952 week low−31.1%
Indicators
RSI (14)
37.95
Weak, oversold below 30
Neutral
MACD
0.14
Below its signal line
Bearish
Stochastic
11.5
Near the bottom of its range
Oversold
ADX (14)
31.2
Trending down
Williams %R
-97.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-139.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−46.5%
Change over 10 sessions
Bearish
ATR (14)
$1.24
Typical daily range, 33.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XGN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how XGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow XGN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How XGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XGN is in one of them and how their past XGN trades turned out.
Exagen is a medical technology company based in Vista, California, that makes diagnostic tests for autoimmune and related rheumatic diseases. Its main product line, sold under the AVISE brand, includes AVISE CTD, which helps clinicians tell apart conditions with overlapping symptoms, such as lupus and rheumatoid arthritis. Its tests are used mainly by rheumatologists, with primary care physicians, other specialists, hospitals and healthcare systems also among its customers. The company runs its own clinical laboratory to process the tests.